Takehiro Inoue

Suggest Changes
Learn More
PURPOSE To improve results for localized prostate cancer, a prospective clinical trial of hyperfractionated Iridium-192 high-dose-rate (HDR) brachytherapy as a monotherapy was initiated. METHODS(More)